The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
"Brokers are being asked to guide clients through rising regulatory pressure, economic uncertainty and AI adoption all at once," said Jura Slattery, chief customer officer at isolved.
A number of factors can contribute to drug shortages, including supply chain disruptions, a limited number of manufacturers, regulatory burdens, small profit margins, natural disasters and unforeseen surges in demand for certain drugs.
"In 2025, shadow AI surged across health care organizations as staff across all aspects of care sought ways to improve efficiency amid persistent burnout, staffing shortages and other factors," said Alex Tyrell, senior vice president and chief technology officer at Wolters Kluwer.
The goal of the program, according to the agency, is to increase regulatory predictability, facilitate the construction of manufacturing sites in the United States and streamline aspects of pharmaceutical manufacturing facility assessments in advance of a specific product application.
Health care fraud remained a leading source of settlements and judgments with more than $5.7 billion of the total settlements and judgments last year were related to matters involving the industry.
This case is part of a broader effort by the attorney general's office to examine electronic health record vendors' compliance with Texas laws governing parental access to minors' health records.
The objective of the Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE) is to develop technology that could schedule appointments, adjust medications and support diet and exercise.